2022 Society of Urologic Cancer Annual Meeting recap - SUO/YUO research highlight


“The takeaway from that talk was that it's critically important to review drug plan options, particularly if the patient's on a high-cost drug,” says Kelly L. Stratton, MD, FACS.

In this video, Kelly L. Stratton, MD, FACS, recaps a presentation from the 2022 Society of Urologic Oncology Annual Meeting Young Urologic Oncologists Program regarding cost savings for prostate cancer treatments. Stratton is an assistant professor of urologic oncology at the University of Oklahoma, Oklahoma City.

Related Videos
Rachel Rubin, MD, answers a question during a video interview
© 2023 MJH Life Sciences

All rights reserved.